@Un1qu3Nam3
Curaleaf although spreading it's double headed wings across US & Canada is one of my least favorites. Backed by Renaissance Capital and by same russian $ as uranium one deal.
https://m.benzinga.com/article/12764796?utm_referrer=https%3A%2F%2Fwww.google.com%2F&utm_source=https%3A%2F%2Fwww.google.com%2F
All imo.
As many of us have said although a much longer wait BOT will be in the prime FDA position to take advantage whilst the rest are trying to play catch up.
The Green Fund-Best pot stocks 2019, page-43
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
-0.010(2.50%) |
Mkt cap ! $693.8M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 40.0¢ | 38.3¢ | $1.751M | 4.449M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 285202 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 347270 | 12 |
View Market Depth
| Last trade - 14.04pm 03/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |